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The harsh realities of life in a terrestrial environment demand that the epidermis must respond quickly
to many types of external stressors that threaten the internal milieu. We review herein how the indi-
vidual protective functions of the skin (e.g., permeability barrier, antimicrobial barrier, antioxidant de-
fense, integrity, hydration, and mechanical integrity) appear to be integrated into a broad defensive
shield. Then, we will review how the epidermis responds to external perturbations through a network of
extracellular signaling mechanisms and second messengers, as well as the pathophysiology of these
responses in diseases such as atopic dermatitis and psoriasis. Finally, we will brieﬂy discuss the potential
therapeutic implications of this new functional paradigm.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Too long viewed as a mere battleground for the immune system,
the epidermis is asserting its rightful place at the center of cuta-
neous biology and pathophysiology. Although immunologists seek
ever-ﬁner distinctions between T cell subsets in inﬂammatory le-
sions, it is now increasingly clear that the protective requirements
of the skin dictate virtually every metabolic process (including
adaptive immune responses) in its underlying layers. True, there
are “outside-to-inside-back-to-outside” vicious cycles, whereby
immune responses further compromise epidermal function, and
there are also examples of primary immune disorders, such as
autoimmune and bullous diseases, human immunodeﬁciency virus
(HIV) infections, and superantigen-initiated ﬂares of erythrodermic
psoriasis, where a primary inﬂammatory inﬁltrate can produce
downstream abnormalities in epidermal function (e.g., for HIV, see
Gunathilake et al1). But, as the example of ﬁlaggrin-deﬁcient atopic
dermatitis (AD) eloquently demonstrates, most cutaneous immune
phenomena occur downstream of primary epidermal insults,
whether inherited or acquired, and these responses are recruitedy have no ﬁnancial or non-
atter or materials discussed
edical Center, San Francisco
150 Clement Street, MS 190,
cal Association. Published by Elsevonly when epidermal homeostatic responses fail to promptly
reestablish normal cutaneous function. In this review, we consider:
(1) a new “holistic” view of epidermal defense; (2) a concise review
of the structural basis for the barrier with an update on tight
junctions (TJs) and the corneocyte lipid envelope; (3) intra-
epidermal metabolic processes that are regulated by barrier re-
quirements; (4) the role of homeostatic signaling mechanisms in
regulating these responses; and (5) interrelated processes that
impact disease pathogenesis.Brief review of barrier structure and function
Two-compartment model
The protective functions of the skin, including the permeability
barrier, largely localize to the outer epidermis and stratum cor-
neum (SC; Table 1; Figure 1). The SC is an a nucleate structure,
arranged in a “brick-and-mortar” mosaic of ﬂattened corneocytes
(“bricks”), embedded in lipid-enriched extracellular matrix
(“mortar”) that is organized into parallel stacks of lamellar bilayers,
enriched in ceramides, cholesterol, and free fatty acids (FFAs).2
These water-repellent lipids restrict the outward ﬂow of water,
while also impeding the inward absorption of toxins, allergens, and
microbial pathogens.3 It is the secretion of the contents of multiple,
small ovoid lamellar bodies (LBs)2 that delivers both lipid pre-
cursors and hydrolytic “processing” enzymes that generate the
hydrophobic species, ceramides (Cer), FFAs, and cholesterol, thatier Taiwan LLC. All rights reserved.
Table 1 Defensive gradients in outer epidermis.
Functions Outer surface (sebaceous glands) Stratum corneum Stratum granulosum
Antimicrobial AMP, FFA (Y pH) FFA (Y pH), AMP, SPI AMP, TLR
Permeability barrier d Cholesterol, Cer, FFA in lamellar bilayers Tight junction (larger xenobiotes)
Antioxidant Vitamin E Vitamin E, Sprr2d, Sprr2h, Slpi SOD, CoQ, catalase, GluTR
UV-B d t-UCA (melanin) Melanin
Mechanical d Corniﬁed envelopes d
Cohesion d Lipids, corneodesmosomes Desmosomes, adherens junctions
Cytokine activation d IL-1a/b release TNFa, IL-1a/b, GMCSF, IL-6, NGF, AR, VEGF
Neurosensory d d TRPVs, TRPM8
Hydration Glycerol FLG/ NMF; glycerol, urea AQP channels
Urea transporters
AMP ¼ antimicrobial peptide; Cer ¼ ceramide; CoQ ¼ coenzyme Q; FFA ¼ free fatty acid; GM-CSF ¼ granulocyte-macrophage colony-stimulating factor; GluTR ¼ glutamyl
tRNA reductase; IL ¼ interleukin; NGF ¼ nerve growth factor; NMF ¼ natural moisturizing factor; Slpi ¼ serine leukocyte protease inhibitor; SOD ¼ superoxide dismutase;
SPI¼ serine protease inhibitor; TLR¼ Toll-like receptor; TNF¼ tumor necrosis factor; TRPM8¼ transient receptor potential melastatin-8; TRPV¼ transient receptor potential
vanilloid; t-UCA ¼ trans-urocanic acid; VEGF ¼ vascular endothelial growth factor.
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along with as-yet-unidentiﬁed amphiphilic molecules, are required
for the organization of the secreted lipids into mature lamellar
bilayers.2
Corneocyte-bound lipid envelope
The external surface of the corniﬁed envelope (CE) is coated with a
monolayer of u-hydroxyceramides (u-OH-Cer) that are covalently
bound to peptides (1 involucrin) within the CE.5e7 Both the origin
and the function of this structure are still uncertain. Although most
workers believe that it is formed from a pool of secreted acylCer, the
corneocyte-bound lipid envelope (CLE) could also derive from the
insertion of a myriad of LB limiting membranes during the exocy-
tosis of these organelles.4 We noted that the CLE fails to form in
several inherited and acquired disorders that compromise steps
that either generate acylCer or oxidize the u-OH-linoleate moiety
of acylCer (Figure 2). Because all of these disorders are character-
ized by a faulty permeability barrier, poor SC hydration, and
impaired desquamation, it is a tempting (but still not certain)
prospect that the CLE is linked to one or more of these functions.4
TJ controversy
How should we interpret an ever-expanding literature that pro-
claims a potential role for TJ in normal permeability barrierFigure 1 Protective (defensive) functions arefunction (e.g., see Brandner et al8 and Kubo et al9), as well as a
potential role for abnormal TJ function in AD?10 We will attempt to
navigate this heavily invested subject as follows. First, complex TJ
structures, such as those found in the kidney and gastrointestinal
tract, do not occur in adult keratinizing epithelia.11 Second, with the
exception of highly complex TJs in renal collecting tubules, where
they comprise multitiered, overlapping sites of membrane fusion
(“zonulae occludentes”), in other tubular epithelia, such as the
trachea and gastrointestinal tract, these junctions provide a rela-
tively poor barrier against paracellular water movement.12,13 Much
of the confusion in the skin-related literature has occurred because
“TJ proteins” are widely equated with “TJ”.8,9,14 Certainly, multiple
TJ proteins heavily decorate the apicalelateral plasma membranes
of cells in the outer stratum granulosum (SG) of normal adult
epidermis, forming “kissing points.” However, these focal
attachmentsdi.e., “maculae occludentes”11ddo not comprise true
zonulae occludentes (¼ TJ), as occur in tubular epithelia. The most
compelling evidence that these putative TJs play no direct role in
the paracellular water barrier comes from solvent extraction
studies, where removal of SC lipids by repeated, gentle, lipid sol-
vent swabbing completely abrogates the permeability barrier.15 It
should be noted that this observation also excludes a possible
“backup” role for TJ-like structures in the water barrier, although it
remains possible that true TJs eventually could begin to form in
response to such repeated solvent wipes. Moreover, these incom-
plete structures could sufﬁce to interdict the paracellular passage ofrelated, coregulated and interdependent.
Figure 2 Pathways leading to corneocyte-bound lipid envelope (CLE) formation: insights from inherited and acquired lipid metabolic disorders. Note. From “Formation and
functions of the corneocyte lipid envelope (CLE),” by P.M. Elias, R. Gruber, D. Crumrine, et al., 2014, Biochim Biophys Acta, 1814, p. 314e8. Copyright 2014, Elsevier. Adapted with
permission.
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barrier becomes defective, as occurs in atopic dermatosis.10
Yet, these structures, although insufﬁcient to contribute directly
to the normal water barrier, are nonetheless critical for the devel-
opment of permeability barrier competence. Transgenic knockout
of the key TJ protein, claudin 1, results in a fatal, postnatal
permeability barrier abnormality.14 Indeed, our recent studies
show that replete TJs are present early in epidermal development,
but they become functionally incompetent later in fetal life in
parallel with the establishment of the lipid-based barrier.16 Because
adult epidermis does not generate the types of complex zonulae
occludentes necessary to impede paracellular water movement,
attention should be focused instead on the possible functions of
these incomplete junctions (maculae occludentes) in normal
epidermis, and how acquired defects in such focal connections
could contribute to disease pathogenesis. We believe that these
structures perform important “fence functions” in adult epidermis,
including polarizing the direction of LB secretion toward the apex of
the outermost granular layer,17 while also restricting selected
membrane transporters, such as the sodiumehydrogen antiporter
1 (NHE1), to the apical plasma membrane of these cells.
Although an acquired reduction in the expression of the TJ
protein, claudin 1, has been reported in AD,10 treatment of cultured
human keratinocytes with the T helper 2 cytokine, interleukin-4,
instead upregulates claudin 1 expression, while simultaneously
downregulating another TJ protein, occludin (Y. Hatano, personalTable 2 How permeability and antimicrobial barriers are linked.
1. Colocalization of both functions to extracellular (“mortar”) domains
2. Pathogens attempt to invade through SC extracellular domains
3. Some permeability barrier lipids (e.g., free fatty acids and sphingosine) exhibit pote
4. Certain AMPs localize to lamellar bodies (along with lipids) and are codelivered to S
5. Both AMP expression and secretion accelerate after permeability barrier disruption,
6. At least one AMP (LL-37) is required for permeability barrier homeostasis
7. Certain serine proteases (e.g., SLPI) that regulate SC cohesion also exhibit potent an
AMP ¼ antimicrobial peptide; SC ¼ stratum corneum; SLPI ¼ secretory leukocyte proteacommunication). Moreover, occludin (but not claudin) protein
levels decline in ﬁlaggrin-deﬁcient human epidermis.18 Hence,
should abnormalities in TJ proteins occur in AD, they likely result
from the T helper 2-dominant milieu that downregulates many
other epidermal differentiation-linked proteins (e.g., see Howell
et al19).
Interdependence of, and interrelationships between,
epidermal defensive functions
Although it is common practice to list the various defensive func-
tions of the skin as discrete processes (Table 1), in most cases, these
functions are interrelated, coregulated, and interdependent. As is
evident from Figure 1, more and more connections are emerging
between these defensive functions, of which we will highlight only
a few for consideration here. Best appreciated are the connections
between the permeability barrier and antimicrobial defense.
Shared structural and biochemical,20 as well as common metabolic
processes, unite these two functions (Table 2).
Moreover, epidermal LBs provide a common delivery mecha-
nism for components with overlapping functions, such as FFAs and
antimicrobial peptides (Table 2), of which at least one, the cath-
elicidin carboxyterminal peptide, LL-37, is required not only to
restrict pathogen invasion, but also as an apparent structural
component of lamellar bilayers.21 In multiple clinical situations, in
experimental perturbations, and after applications of therapeuticnt antimicrobial activity
C extracellular domains
paralleling upregulation of lipid synthesis
timicrobial activity
se inhibitor.
Figure 3 Parallel changes in barrier function and cathelicidin expression. Note. From
“Expression of epidermal CAMP changes in parallel with permeability barrier status,”
by M. Rodriguez-Martin, G. Martin-Ezquerra, M.Q. Man MQ, et al., 2011, J Invest Der-
matol, 131, p. 2263e70. Copyright 2011, Dr. Peter Elias. Adapted with permission.
P.M. Elias, J.S. Wakeﬁeld / Dermatologica Sinica 33 (2015) 49e5752ingredients that either compromise or improve permeability bar-
rier homeostasis, corresponding alterations occur in LL-37, and to a
lesser extent, human beta-defensin 2 (hBD2) expression
(Figure 3).21,22
LBs also deliver proteases and antiproteases that initially regu-
late SC cohesion, and then orchestrate the digestion of
corneodesmosomes23e26 (Figures 4 and 5). However, corneo-
desmosome degradation is only the ﬁrst in a series of subsequent
cellular events that leads to the eventual shedding of corneocytes
from the skin surface26 (Figure 5). Finally, as noted above, LBs also
secrete at least two antimicrobial peptides, hBD2 and LL-37, into the
SC extracellular domains.27e29 Because they appear to be so inter-
twined, it becomes a matter of semantics as to whether not only
these two, but also whether several other functions, should be
considered discrete or interrelated processes (Figure 1). There are
pathogenic implications of LBs as an integrated delivery system.
Not only permeability barrier function, but also antimicrobial de-
fense and SC cohesion, are compromised in AD, and as shown in
Figure 6 their altered gene products all converge on the LB secre-
tory system.
The multiple functions that are impacted by the epidermal
structural protein, ﬁlaggrin, serve as another illustrative example of
the link between multiple defense functions. First, the full-lengthFigure 4 Diagram of stratum corneum membrane domains. Note. From “Thematic Review S
epidermal biology,” by M. Schmuth, Y.J. Jiang, S. Dubrac, P.M. Elias, K.R. Feingold KR, 2008,protein becomes a component of the CE,30,31 contributing to
epidermal mechanical defense.18 We have shown that an intact CE
is required for the supramolecular organization of secreted lipids
into lamellar bilayers, as eloquently demonstrated in two disorders
of corniﬁcation, transglutaminase 1-deﬁcient lamellar ichthyosis32
and loricrin keratoderma.33 But it is the subsequent, humidity-
dependent proteolysis of FLG above the mid-SC34 that impacts an
even broader suite of functions35 (Figure 7). Following FLG hydro-
lysis, its constituent amino acids are further deiminated, both
enzymatically and nonenzymatically, into a suite of polycarboxylic
acids (“natural moisturizing factor”) that not only account for much
of SC hydration, but also contribute to defense against UV-B and to
the acidiﬁcation of the SC (Figure 7). The reduced pH of the SC, in
turn, is critical for multiple functions, including not only antimi-
crobial defense, but also permeability barrier homeostasis,36 SC
cohesion, and proinﬂammatory cytokine activation.
We next highlight another example of linked functions that
recently emerged from the laboratory of SabineWerner (Institute of
Cell Biology, Zurich, Switzerland), who showed that a key tran-
scription factor, nuclear factor erythroid 2-related factor 2 (Nrf2),
regulates the expression of two CE precursors, small proline-rich
proteins (Sprr2b and Sprr2h). This transcription factor also regu-
lates expression of a potent antimicrobial protein, secretory
leukocyte protease inhibitor (Slpi), which is also an inhibitor of
serine proteases (kallikreins) that regulate SC cohesion37 (Figure 8).
The cohesiveness of the SC, in turn, is critical for both permeability
barrier function and antimicrobial defense. Together, these exam-
ples of functional links illuminate how discrete epidermal protec-
tive functions should instead be considered components of a
broader, protective “superfunction” of the skin.
Metabolic mechanisms that maintain epidermal homeostasis
Life in a terrestrial environment requires constant vigilance,
accompanied by responses, either draconian or subtle, to external
perturbations that potentially threaten the organism with desic-
cation, microbial invasion, oxidant damage, UV-B-induced
apoptosis, and/or impaired mechanical defense. Consider the
most dramatic example, i.e., an external thermal burn, with its
potentially devastating consequences. The foremost threat to such
patients, of course, is rapid desiccation owing to an unrestricted
loss of internal ﬂuids and electrolytes, as well as an increased
susceptibility to pathogen invasion. Yet, even following such
potentially catastrophic injuries, the skin attempts to repair itself.
What is the driving force behind the repair of such wounds? Entire
generations of surgeons and skin biologists have focused onceeries: Skin Lipids. Peroxisome proliferator-activated receptors and liver X receptors in
J Lipid Res, 49, p. 499e509. Copyright 2008, Dr. Peter Elias. Adapted with permission.
Figure 5 Basis for normal exfoliation: summary of observations. aCer'ase ¼ acidic ceramidase; CD ¼ corneodesmosome; CE ¼ corniﬁed envelope; DSC1 ¼ desmocollin 1;
DSG1 ¼ desmoglein 1; SC ¼ stratum corneum. Note. From “Cellular changes that accompany shedding of human corneocytes,” by T.K. Lin, D. Crumrine, L.D. Ackerman, et al., 2012, J
Invest Dermatol, 132, p. 2430e9. Copyright 2012, Dr. Peter Elias. Adapted with permission.
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initial inﬂammatory responses, platelet-derived growth factors,
granulation tissue, collagen remodeling, and/or wound contracture
as key “drivers” of wound healing. Reepithelialization often is noted
only in passing as the inevitable downstream consequence of these
earlier events. Few, if any, of these investigators have considered
the possibility that it could be the “imperative to reestablish
permeability barrier homeostasis” that likely “drives” much of the
wound healing sequence, which includes reepithelialization fol-
lowed by stratiﬁcation of epidermis into a functional SC. They need
only observe that occlusion with vapor-permeable wraps delays
wound healing, whereas applications of vapor-permeable wrapsFigure 6 How inherited abnormalities in AD produce defective permeability and antimicro
FA ¼ fatty acid; Fatp4 ¼ fatty acid transport protein 4; Flg ¼ ﬁlaggrin; hBD2 ¼ h
LEKTI ¼ lymphoepithelial Kazal-type trypsin inhibitor.stimulate all of the processes described above, including
reepithelialization.
We view one of our standard laboratory models, i.e., sequential
tape stripping, as a type of superﬁcial wound. Tape stripping (no
different than either detergent or solvent wipes) produces a defect
in the permeability barrier, and all three of these unrelated, acute
perturbations stimulate an identical series of metabolic responses
in the underlying epidermis that rapidly re-establishes perme-
ability barrier homeostasis in a predictable sequence, and with
characteristic kinetics (Table 3). This approach (which we term the
cutaneous stress test or “treadmill of the skin”) can be deployed to
identify speciﬁc metabolic responses that bring aboutbial barriers. AD ¼ atopic dermatitis; CNDS ¼ corneodesmosin; DSG1 ¼ desmoglein 1;
uman beta-defensin 2; Hrn ¼ hornerin; KLK ¼ kallikrein; LB ¼ lamellar body;
Figure 7 Multiple downstream consequences of ﬁlaggrin deﬁciency in atopic dermatitis. *Trans-urocanic acid (t-UCA) is the most potent endogenous UV-B ﬁlter in lightly pig-
mented skin. Loss of t-UCA could account for the higher incidence of nonmelanoma skin cancers in atopic dermatitis (AD). Casp 14 ¼ caspase 14; KLK ¼ kallikrein; NMF ¼ natural
moisturizing factor. Note. From “Ichthyosis vulgaris: the ﬁlaggrin mutation disease,” by J.P. Thyssen, E. Godoy-Gijon, P.M., Elias PM, 2013, Br J Dermatol, 168, p. 1155e66. Copyright
2013, Dr. Peter Elias. Adapted with permission.
Figure 8 Nrf2 regulates not only antioxidant defense, but also barrier function and
antimicrobial defense (through increased corniﬁed envelopes and Slpi expression).
Nrf2 ¼ nuclear factor erythroid 2-related factor 2; Slpi ¼ secretory leukocyte protease
inhibitor; Sprr ¼ small proline-rich protein. Note. From “Nrf2 links epidermal barrier
function with antioxidant defense,” by M. Schafer, H. Farwanah, A.H. Willrodt, et al.,
2012, EMBO Mol Med, 4, p. 364e79. Copyright 2012, Dr. Sabina Werner. Adapted with
permission.
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acute barrier perturbations is the immediate secretion (within
15e20 minutes) of much of the preformed pool of LBs from cells of
the outer SG.17 After exteriorizing their cargo of LB contents, these
outermost SG cornify, i.e., they undergo physiologic apoptosis,38
followed immediately by the apical migration of subjacent SG
cells17 (Table 3).
Yet, barrier perturbations also stimulate injury responses that
may be unrelated to the restoration of barrier function. ToTable 3 Chronology of metabolic response to acute barrier disruption.
Event Secretion of preformed





Known signals Y Ca2þ KLK/ PAR2 SRE
Effects of occlusion Blocks Blocks Bloc
and
AR ¼ amphiregulin; IL ¼ interleukin; KLK ¼ kallikrein; NGF ¼ nerve growth factor; PA
proteins; VEGF ¼ vascular endothelial growth factor.distinguish among these two events, one can artiﬁcially restore
barrier function with a vapor-impermeable wrap, such as a Latex
glove or a sheet of Saran wrap. By sending a “message” that the
barrier function is now normal, these forms of occlusion shut
down metabolic events that are solely directed at restoring bar-
rier function, including virtually all of the changes shown in
Figure 939 and Table 3.40 Yet, some responses, such as increased
cytokine production (see below), are not blocked by occlusion.
These could be dual-purpose, i.e., signals of both barrier ho-
meostasis and an injury response. Finally, it should be noted that
the same “stress test” approach has allowed us to identify ab-
normalities in barrier function in the following: (1) develop-
mental (neonatal and aged skin) settings41,42; (2) human
populations, subjected to psychological stress,43 or endowed with
different pigment types44,45; and (3) disease settings.46,47 Finally,
the stress test led to the development of new generations of
“barrier repair” therapeutics48 as well as novel metabolically
based, drug delivery technologies.49Signals of barrier homeostasis
It still is only partially understood how perturbations of the
outer skin surface signal the underlying nucleated layers to
initiate the metabolic responses that restore permeability barrier
homeostasis. To date, several extracellular signaling mechanisms
have been identiﬁed that are known to stimulate a broad array of
metabolic responses in the underlying epidermis50 (Figure 10;
Table 4). However, it also should be noted that external pertur-
bations “turn on” intracellular signaling mechanisms (second
messengers) that also regulate these metabolic responses
(Table 5).
These include the “liposensor” subclass of nuclear hormone re-
ceptors [peroxisome proliferator-activated receptor (PPAR) a,pid synthesis
cretion
[ Lipid processing [ DNA synthesis
BPs; [ IL-1a; Y Ca2þ ? AR, NGF, IL-1a
ks both lipid synthesis
transport
Blocks Blocks DNA synthesis;
blocks AR, NGF, VEGF
(but not cytokine) production
R2 ¼ proteinase-activated receptor 2; SREBPs ¼ sterol regulatory element binding
Figure 9 Lipid metabolic events leading to normal barrier formation. b-GlcCer'ase ¼ b-glucocerebrosidase; aSMase ¼ acidic sphingomyelinase; FATPs ¼ fatty acid transport
proteins; sPLA2 ¼ secretory phospholipase A2; SSase ¼ steroid sulfatase. Note. From “Role of lipids in the formation and maintenance of the cutaneous permeability barrier,” by K.R.
Feingold and P.M. Elias, 2014, Biochim Biophys Acta, 1841, p. 280e94. Copyright 2014, Elsevier. Adapted with permission.
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transcription of several genes that are critical for epidermal differ-
entiation and lipid production25,51 (Figure 11). Also carefully studied
are sterol regulatory element binding proteins that modulate
epidermal sterol and triacylglyceride synthesis.52 Then, barrierFigure 10 Regulation of permeability barrier repair. Examples of how disruption of the pe
AO ¼ antioxidants; Ca ¼ calcium; l IL-1a ¼ interleukin-1alpha; K ¼ potassium; Klks ¼ kallikr
factor 2; PAR2 ¼ proteinase-activated receptor 2; TSLP ¼ thymic stromal lymphopoietin. N
Schmuth, and P.M. Elias, 2007, J Invest Dermatol, 127, p. 1574e6. Copyright 2007, Dr. Peter Edisruption stimulates hyaluronic acid production, whichddepend-
ing on fragment sizedregulates epidermal proliferation, differen-
tiation, and cholesterol synthesis,53 nitric oxide production, and
endoplasmic reticulum stress responses. It should be noted, how-
ever, that egregious external insults result in cell death or apoptosisrmeability barrier results in signals that can either accelerate or delay barrier repair.
eins; LB ¼ lamellar bodies; NO ¼ nitric oxide; Nrf2 ¼ nuclear factor erythroid 2-related
ote. From “The regulation of permeability barrier homeostasis,” by K.R. Feingold, M.
lias. Adapted with permission.
Table 4 Signals that regulate permeability barrier homeostasis.
Extracellular modulations Sensor Signal Homeostatic responses Potential pathogenic signala
External humidity TRPV4, TRPM8 Ca2þ Lamellar body secretion;
Ye[ Epidermal differentiation
No








[ AMP production, antiapoptotic ([ HSPs)
No
Acidity TRPV1 Ca2þ [ NHE1 þ ? others Yes (via SP/ PAR2)
Barrier disruption DpH Cytokines;
Klk/PAR2
[ Epidermal proliferation;
[ lipid synthesis/secretion (IL-1a);
terminal differentiation
Yes (inﬂammation, pruritus)
Heat TRPV3, Ca2þ ?Ca2þ ? No
Injury (wounding) TLR3 ncRNA [ Lipid synthesis þ secretion;
[ innate immunity
Yes (inﬂammation)
AQP ¼ aquaporin; BGT1 ¼ betaine/gamma-amino-n-butyric acid transporter 1; Chol ¼ cholesterol; HSP ¼ heat shock protein; Klk ¼ kallikrein; ncRNA ¼ noncoding RNA;
NHE1 ¼ sodiumehydrogen antiporter 1; PAR2 ¼ protease-activator receptor 2; TauT ¼ taurine transporter; TLR3 ¼ Toll-like receptor 3; TonEBP ¼ tonicity enhancer binding
protein; TRPM8 ¼ transient receptor potential melastatin-8; TRPV ¼ transient receptor potential vanilloid.
a Failed to downregulate with artiﬁcial barrier restoration following acute perturbation.
Table 5 Second messengers of permeability barrier homeostasis.
External perturbations Signal Homeostatic response Potential pathologic signal
Barrier disruption,
UV-B, oxidative stress
ER stress/[Cer/ [S1P [ Epidermal CAMP (LL-37) production Cell death, apoptosis, if excessive
d [Cholesterol sulfate/ PKGh,
AP1 elements
[ Epidermal differentiation Abnormal SC cohesion and barrier function
Barrier disruption SREBPs [ Sterol, triacylglycerol synthesis No
Barrier disruption PPARs, LXR [ Epidermal differentiation, lipid synthesis No





Nitric oxide/ [cGMP, [Ca2þ Y Barrier repair Inﬂammation; apoptosis
CAMP ¼ cathelicidin antimicrobial peptide; ER ¼ endoplasmic reticulum; LXR ¼ liver X receptor; PPAR ¼ peroxisome proliferator-activated receptors;
SREBPs ¼ SREBPs ¼ sterol regulatory element binding proteins.
P.M. Elias, J.S. Wakeﬁeld / Dermatologica Sinica 33 (2015) 49e5756(Figure 10), by one or more of these mechanisms.54 In addition, the
sulfated sterol, cholesterol sulfate, which is generated late in
epidermal differentiation, is a potent transcriptional regulator of
epidermal differentiation.55 Yet, new signaling networks, both ex-
tra- and intracellular, that link external perturbations to metabolic
response in the underlying epidermis continue to be discoveredFigure 11 Speculative diagram that illustrates coordinate regulation of epidermal barrier h
nuclear hormone receptors. ABCA12 ¼ ATP-binding cassette transporter A12; FFA ¼ free f
SREBP ¼ sterol response element binding transcription factor. Note. From “Coordinate regu
Feingold, 2001, Skin Pharmacol Appl Skin Physiol, 14, p. 28e34. Copyright 2001, Dr. Peter Elia(Tables 4 and 5). Whereas several of these signals broadly regulate
epidermal differentiation and/or lipid production, perhaps in a
redundant or overlapping fashion, others modulate more discrete
metabolic pathways within the epidermis.
It is important to distinguish whether these signaling mecha-
nisms represent purely homeostatic or, in part, injury-mediatedomeostasis by changes in calcium, and activation of the liposensor subclass of class-II
atty acid; LXR ¼ liver-x receptor; PPAR ¼ peroxisome proliferator-activated receptor;
lation of epidermal differentiation and barrier homeostasis,” by P.M. Elias PM and K.R.
s. Adapted with permission.
P.M. Elias, J.S. Wakeﬁeld / Dermatologica Sinica 33 (2015) 49e57 57responses. The “gold standard” applies againddo these signals
deploy followingacute external perturbations, evenwhen thebarrier
is immediately restored by occlusion (see also above)? Several cy-
tokines, but not the growth factors NGF (nerve growth factor), AR,
and VEGF (vascular endothelial growth factor), continue to upregu-
late, even in the face of barrier restoration by occlusion, indicating
that they could represent, at least in part responses to injury, rather
than purely homeostatic mechanisms alone (Tables 4 and 5).
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